bioAffinity Technologies, Inc.

BIAF Healthcare Diagnostics & Research

In the quarter to June 2026, revenue grew 19.0%, EPS grew 87.5%, free cash flow fell 23.7% and total debt rose 569.7%, each against the same quarter a year earlier.

3.73 0.23 −5.81%
Market cap
$5.1M
P/E
0.0×
Fwd P/E
−0.2×
Dividend yield
—
F-score
2/9
Altman Z
−10.54
Beneish M
−5.49
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.47 0.33 3.04 0.72
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(1.27) (0.79) (5.34) (1.33)
P/B ratio
0.35 0.28 4.70 1.13
Price to Tangible BV
0.47 0.39 11.08 2.53
EV/Sales
(0.64) (0.61) 2.60 0.40
EV/EBITDA
0.44 0.37 0.00 0.00
EV/Operating CF
0.51 0.40 (1.35) (0.21)
EV/FCF
0.51 0.40 (1.35) (0.21)
Quick Ratio
3.44 2.41 1.19 1.24
Current Ratio
3.65 2.60 1.36 1.44
Net Debt/EBITDA
3.44 1.92 0.71 0.57
Debt/Assets
1.58% 6.20% 7.74% 7.28%
Debt/Equity
0.02 0.09 0.17 0.15
Asset Turnover
0.75 0.71 0.84 0.95
Operating CF/Net income
0.49 0.82 0.89 0.95
Capex/Depreciation
0.03 0.00 (0.05) (1.46)
Interest Coverage
(424.59) (239.47) (246.05) (285.03)
Research and Development Expense of Revenue
32.77% 41.99% 50.59% 55.44%
Selling, General and Administrative Expense of Revenue
152.78% 190.68% 239.85% 189.24%
Intangible Assets out of Total Assets
0.19 0.19 0.27 0.27
Share Based Compensation of Revenue
4.65% 4.15% 1.06% 51.97%
Graham Net Nets
1.89 1.91 0.00 0.00
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(707.62%) (1,334.92%) (307.03%) (898.56%)
Free Cash Flow Yield
(269.48%) (462.09%) (63.46%) (272.26%)
Revenue per Share
20.34 13.87 4.51 4.33
Operating CF per Share
(34.88) (22.30) (10.76) (9.18)
Capex per Share
0.05 0.00 (0.02) (0.26)
Free Cash Flow per Share
(34.83) (22.30) (10.78) (9.44)
Cash per Share
107.87 56.18 10.33 6.97
Shareholders Equity per Share
125.21 63.39 12.21 10.81
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
125.21 63.39 12.21 10.81
Free Cash Flow
(2.48) (2.56) (3.23) (3.29)
Working Capital
6.25 4.66 1.16 1.18
Capital Expenditures
0.00 0.00 (0.01) (0.09)
Net Current Asset Value
5.97 3.88 0.06 0.01
EV/EBIT
0.42 0.35 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.06
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
0.89 0.84 0.82 0.66
Average Payables
0.86 0.87 1.11 1.07
Average Inventory
0.03 0.04 0.06 0.06
Average Assets
9.05 8.74 6.75 6.19
Average Common Equity
6.01 4.94 2.55 0.82

Fold the line items

Columns are period end dates · fundamentals updated 2 Oct 2026